Lumi

Learn.xyz Bags $3M Seed Funding; Rolls Out First-of-Its-Kind AI-Powered Social Learning App Globally

Retrieved on: 
Friday, September 15, 2023

SAN FRANCISCO, Sept. 15, 2023 /PRNewswire-PRWeb/ -- Learn.xyz, a generative AI learning startup, announced today the launch of its fully AI-powered social learning app on iOS and Android on the heels of closing a $3 million seed financing round.

Key Points: 
  • The San Francisco-based startup secured the seed funding for its new AI-powered social learning app, now available globally on iOS and Android.
  • Aiming to make casual learning accessible and engaging, the app generates quick educational "Curiosities" from any user question, about any topic imaginable.
  • SAN FRANCISCO, Sept. 15, 2023 /PRNewswire-PRWeb/ -- Learn.xyz , a generative AI learning startup, announced today the launch of its fully AI-powered social learning app on iOS and Android on the heels of closing a $3 million seed financing round.
  • "By making learning casual, fun, and social, we believe we can motivate a massive audience," added CTO and Co-Founder Arndt Voges.

Helios Fairfax Partners Reports First Quarter Financial Results

Retrieved on: 
Wednesday, May 10, 2023

TORONTO, May 10, 2023 (GLOBE NEWSWIRE) -- Helios Fairfax Partners Corporation (TSX: HFPC.U) today announced its financial results for the three months ended March 31, 2023. All dollar amounts in this news release are expressed in U.S. dollars except as otherwise noted. The financial results are derived from the interim consolidated financial statements prepared using International Financial Reporting Standards, except as otherwise noted.

Key Points: 
  • NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
    TORONTO, May 10, 2023 (GLOBE NEWSWIRE) -- Helios Fairfax Partners Corporation (TSX: HFPC.U) today announced its financial results for the three months ended March 31, 2023.
  • The financial results are derived from the interim consolidated financial statements prepared using International Financial Reporting Standards, except as otherwise noted.
  • “The HFP team made significant progress monetizing Legacy Non-Core Investments in the first quarter of 2023, realizing of $28 million in proceeds from two Legacy Non-Core Investments.
  • The Annual and Special Meeting of shareholders of Helios Fairfax Partners Corporation (“HFP” or the “Company”) will be held on Thursday, May 11 at 2:00 p.m.

Helios Fairfax Partners to Host Investor Presentation on Wednesday, April 19, 2023 at 2:30 pm ET and Annual General and Special Meeting of Shareholders on May 11, 2023 at 2:00 pm ET

Retrieved on: 
Wednesday, March 15, 2023

TORONTO, March 15, 2023 (GLOBE NEWSWIRE) -- Helios Fairfax Partners Corporation (TSX: HFPC.U) (“HFP”) today announced it will host an Investor Presentation on Wednesday, April 19, 2023 at 2:30 pm ET in-person at the Delta Hotel, 75 Lower Simcoe Street, Toronto, Ontario, and virtually via live webcast. To register in advance and join the Investor Day webcast visit: https://hfpinvestorpresentation.can.chime.live/. On the day of the meeting please connect approximately 15 minutes prior to the beginning of the webcast to ensure participation.

Key Points: 
  • To register in advance and join the Investor Day webcast visit: https://hfpinvestorpresentation.can.chime.live/ .
  • On the day of the meeting please connect approximately 15 minutes prior to the beginning of the webcast to ensure participation.
  • To join the Annual General and Special Meeting of Shareholders webcast visit: web.lumiagm.com/468254283 .
  • On the day of the meeting please connect approximately 15 minutes prior to the beginning of the webcast to ensure participation.

Leading Independent Proxy Advisors ISS and Glass Lewis Recommend Capstone Shareholders Vote FOR the Proposed Arrangement with Mantos Copper

Retrieved on: 
Tuesday, February 15, 2022

ISS and Glass Lewis are two leading independent, third party proxy advisory firms who, among other services, provide proxy-voting recommendations to pension funds, investment managers, mutual funds and other institutional shareholders.

Key Points: 
  • ISS and Glass Lewis are two leading independent, third party proxy advisory firms who, among other services, provide proxy-voting recommendations to pension funds, investment managers, mutual funds and other institutional shareholders.
  • The merger will result in a larger, more diversified copper producer with an opportunity to achieve meaningful synergies.
  • The meeting materials are available on SEDAR and on the Companys website at Capstone Mining - Investors - Special Meeting of Shareholders .
  • The Capstone Board of Directors UNANIMOUSLY recommends that Shareholders Vote IN FAVOUR of the Transaction.

Plant-Based Pioneer Lumi Foods (formerly Blue Heron Creamery) Announces $10.8M Development and Distribution Co-Investment Alongside New Woman-Led C-Suite

Retrieved on: 
Monday, January 31, 2022

The new products will be built out for distribution into 260+ Save On Foods locations in Canada.

Key Points: 
  • The new products will be built out for distribution into 260+ Save On Foods locations in Canada.
  • As a consortium, Winecrush Technologies, Save On Foods, and Lumi Foods aim to create a new vegan cheese culture for all Canadians.
  • Blue Heron Creamery was co-founded by McAthy, when the then-executive-chef-turned-author was conducting research for her first book,The Art of Plantbased Cheesemaking(2017).
  • Today, Blue Heron Creamery is the foundation of the Lumi Foods brand.

New partnership will enhance Canada’s plant-based cheese market

Retrieved on: 
Tuesday, January 18, 2022

VANCOUVER, British Columbia, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Today, Protein Industries Canada announced a new project that will leverage the combined strengths of Lumi Foods (legacy brand Blue Heron Creamery), Winecrush Technology and Save-On-Foods to enhance Canadas plant-based cheese market.

Key Points: 
  • VANCOUVER, British Columbia, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Today, Protein Industries Canada announced a new project that will leverage the combined strengths of Lumi Foods (legacy brand Blue Heron Creamery), Winecrush Technology and Save-On-Foods to enhance Canadas plant-based cheese market.
  • Their development represents a step forward in the plant-based cheese realm, both in terms of labelling and ingredient use, as most plant-based cheeses are currently made from ingredients sourced outside of Canada.
  • In addition to expanding this line of cheeses, the partners are also dedicated to strengthening Canadas plant-based cheese sector as a whole.
  • Together with industry, theyve invested more than $451 million into Canadas plant-based food, feed and ingredients ecosystem.

CES 2022 Showcases Matter Momentum and a Wave of News from Connectivity Standards Alliance Members

Retrieved on: 
Tuesday, January 11, 2022

"It was great to see increased momentum at CES for Matter support by large and small brands across the smart home ecosystem," said Creative Strategies' Carolina Milanesi.

Key Points: 
  • "It was great to see increased momentum at CES for Matter support by large and small brands across the smart home ecosystem," said Creative Strategies' Carolina Milanesi.
  • For details of the Matter related announcements made during CES 2022 by CSA members, please visit our LinkedIn posts and follow us for upcoming news as it becomes available.
  • The Connectivity Standards Alliance, formerly the Zigbee Alliance, is the foundation and future of the Internet of Things (IoT).
  • Find out more about the Alliance at www.csa-iot.org , and Matter at www.buildwithmatter.com ; or follow us on: Twitter Facebook LinkedIn .

POET Technologies Announces Design Win and Purchase Order from Leading Systems Company

Retrieved on: 
Tuesday, October 5, 2021

The combined value of the NRE and the purchase order for initial units exceeds US$1.2 million.

Key Points: 
  • The combined value of the NRE and the purchase order for initial units exceeds US$1.2 million.
  • The Company also reported that its unaudited cash balance at September 30, 2021 stood at approximately US$20 million.
  • POET Technologies will hold its Annual General and Special Meeting virtually via the Lumi NA on-line platform at 1:00pm EDT on Thursday, October 7, 2021.
  • POET is headquartered in Toronto, with operations in Allentown, PA, Shenzhen, China and Singapore.

Illumina Appoints Susan Tousi as Chief Commercial Officer and Dr. Alex Aravanis as Chief Technology Officer, Head of Research and Product Development

Retrieved on: 
Monday, May 17, 2021

b'Illumina, Inc. (NASDAQ: ILMN) today announced that it is appointing Susan Tousi as Chief Commercial Officer (CCO), and Dr. Alex Aravanis as Chief Technology Officer (CTO), Head of Research and Product Development.\n\xe2\x80\x9cWe\xe2\x80\x99re fortunate to have Susan and Alex, two of the strongest leaders in the genomics industry, take on these large, important roles,\xe2\x80\x9d said Francis deSouza, Chief Executive Officer of Illumina.

Key Points: 
  • b'Illumina, Inc. (NASDAQ: ILMN) today announced that it is appointing Susan Tousi as Chief Commercial Officer (CCO), and Dr. Alex Aravanis as Chief Technology Officer (CTO), Head of Research and Product Development.\n\xe2\x80\x9cWe\xe2\x80\x99re fortunate to have Susan and Alex, two of the strongest leaders in the genomics industry, take on these large, important roles,\xe2\x80\x9d said Francis deSouza, Chief Executive Officer of Illumina.
  • She has received numerous business, technology, and leadership awards, and was elected to the National Academy of Engineers in 2018.
  • \xe2\x80\x9cI look forward to strengthening relationships between Illumina\xe2\x80\x99s research and development teams and our customers, boosting our offerings and benefiting all.
  • Alex returned to Illumina in June 2020 as CTO, leading the company\xe2\x80\x99s research and technology development and the innovation engine for next-generation sequencing platforms and applications.

Illumina and Kartos Therapeutics Announce New Oncology Partnership to Develop an NGS-Based TP53 Companion Diagnostic

Retrieved on: 
Thursday, April 22, 2021

b'Illumina, Inc. (NASDAQ: ILMN) and Kartos Therapeutics, Inc. are pleased to announce a new partnership to co-develop a TP53 companion diagnostic (CDx) based on the content of Illumina\xe2\x80\x99s comprehensive genomic profiling assay, TruSight\xe2\x84\xa2 Oncology 500 (TSO 500).

Key Points: 
  • b'Illumina, Inc. (NASDAQ: ILMN) and Kartos Therapeutics, Inc. are pleased to announce a new partnership to co-develop a TP53 companion diagnostic (CDx) based on the content of Illumina\xe2\x80\x99s comprehensive genomic profiling assay, TruSight\xe2\x84\xa2 Oncology 500 (TSO 500).
  • This companion diagnostic for multiple hematologic indications will be the first to use TSO 500 with peripheral whole blood as a diagnostic sample type.\n\xe2\x80\x9cWith this partnership, Illumina will expand the TruSight Oncology offerings into hematologic malignancies,\xe2\x80\x9d said Phil Febbo, MD, Chief Medical Officer of Illumina.
  • Based on the content of TSO 500, Illumina will be adding an in vitro diagnostic (IVD) test to the TruSight Oncology product family.
  • Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments.